D型肝炎(Hepatitis D):世界の治験レビュー(2014年下半期版)

◆英語タイトル:Hepatitis D Global Clinical Trials Review, H2, 2014
◆商品コード:GDHC2451CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2014年11月30日
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥520,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥780,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、世界におけるD型肝炎(Hepatitis D) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - D型肝炎(Hepatitis D)
  - 当レポートの概要
・D型肝炎(Hepatitis D):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Hepatitis D Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “Hepatitis D Global Clinical Trials Review, H2, 2014″ provides data on the Hepatitis D clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis D. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis D. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Hepatitis D 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Hepatitis D to Infectious Disease Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Hepatitis D to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Hepatitis D Therapeutics Clinical Trials 26
Prominent Drugs 27
Latest Clinical Trials News on Hepatitis D 28
Oct 01, 2014: REPLICor announces initiation of its Phase II clinical trial with REP 2139-Ca in combination with Pegasys in patients with hepatitis B / hepatitis D co-infection 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
F. Hoffmann-La Roche Ltd. 29
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 29
Eiger BioPharmaceuticals, Inc. 30
Clinical Trial Overview of Eiger BioPharmaceuticals, Inc. 30
REPLICor Inc. 31
Clinical Trial Overview of REPLICor Inc. 31
MYR GmbH 32
Clinical Trial Overview of MYR GmbH 32
Merck & Co., Inc. 33
Clinical Trial Overview of Merck & Co., Inc. 33
Hepatera LLC 34
Clinical Trial Overview of Hepatera LLC 34
C. H. Boehringer Sohn AG & Co. KG 35
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 35
Clinical Trial Overview of Top Institutes / Government 36
The National Institute of Diabetes and Digestive and Kidney Diseases 36
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 36
German Liver Foundation 37
Clinical Trial Overview of German Liver Foundation 37
National Taiwan University Hospital 38
Clinical Trial Overview of National Taiwan University Hospital 38
Five Key Clinical Profiles 39
Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 58

List of Tables
Hepatitis D Therapeutics, Global, Clinical Trials by Region, 2014* 6
Hepatitis D Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hepatitis D Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Hepatitis D Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Hepatitis D Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Hepatitis D Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Hepatitis D to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13
Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Hepatitis D to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16
Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Hepatitis D Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Hepatitis D Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Hepatitis D Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Hepatitis D Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Hepatitis D Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Hepatitis D Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Hepatitis D Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Hepatitis D Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 29
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by Eiger BioPharmaceuticals, Inc., 2014* 30
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by REPLICor Inc., 2014* 31
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by MYR GmbH, 2014* 32
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 33
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by Hepatera LLC, 2014* 34
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 35
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 36
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by German Liver Foundation, 2014* 37
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 38

List of Figures
Hepatitis D Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Hepatitis D Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hepatitis D Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Proportion of Hepatitis D to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13
Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Hepatitis D to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16
Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Hepatitis D Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Hepatitis D Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Hepatitis D Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Hepatitis D Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Hepatitis D Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Hepatitis D Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Hepatitis D Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Hepatitis D Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 57

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[D型肝炎(Hepatitis D):世界の治験レビュー(2014年下半期版)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆